JP2016515390A5 - - Google Patents

Download PDF

Info

Publication number
JP2016515390A5
JP2016515390A5 JP2016506253A JP2016506253A JP2016515390A5 JP 2016515390 A5 JP2016515390 A5 JP 2016515390A5 JP 2016506253 A JP2016506253 A JP 2016506253A JP 2016506253 A JP2016506253 A JP 2016506253A JP 2016515390 A5 JP2016515390 A5 JP 2016515390A5
Authority
JP
Japan
Prior art keywords
group
single nucleotide
mrna expression
gene
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016506253A
Other languages
English (en)
Japanese (ja)
Other versions
JP6356217B2 (ja
JP2016515390A (ja
Filing date
Publication date
Priority claimed from KR1020130037336A external-priority patent/KR101501826B1/ko
Application filed filed Critical
Publication of JP2016515390A publication Critical patent/JP2016515390A/ja
Publication of JP2016515390A5 publication Critical patent/JP2016515390A5/ja
Application granted granted Critical
Publication of JP6356217B2 publication Critical patent/JP6356217B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016506253A 2013-04-05 2014-04-07 胃癌に対する予後予測模型の製造方法 Expired - Fee Related JP6356217B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2013-0037336 2013-04-05
KR1020130037336A KR101501826B1 (ko) 2013-04-05 2013-04-05 위암에 대한 예후 예측 모형의 제조방법
PCT/KR2014/002959 WO2014163445A1 (ko) 2013-04-05 2014-04-07 위암에 대한 예후 예측 모형의 제조방법

Publications (3)

Publication Number Publication Date
JP2016515390A JP2016515390A (ja) 2016-05-30
JP2016515390A5 true JP2016515390A5 (enExample) 2017-03-23
JP6356217B2 JP6356217B2 (ja) 2018-07-11

Family

ID=51658661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016506253A Expired - Fee Related JP6356217B2 (ja) 2013-04-05 2014-04-07 胃癌に対する予後予測模型の製造方法

Country Status (6)

Country Link
US (1) US20160040253A1 (enExample)
EP (1) EP2982986B1 (enExample)
JP (1) JP6356217B2 (enExample)
KR (1) KR101501826B1 (enExample)
CN (1) CN105431738B (enExample)
WO (1) WO2014163445A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109923121B (zh) * 2016-11-22 2022-12-23 武汉华大吉诺因生物科技有限公司 多肽及其应用
CN109952308B (zh) * 2016-11-29 2022-09-23 武汉华大吉诺因生物科技有限公司 多肽及其应用
KR102127449B1 (ko) * 2017-02-08 2020-06-26 사회복지법인 삼성생명공익재단 생존율 예측 모델 생성 방법, 장치 및 컴퓨터 프로그램
CN108504732A (zh) * 2017-02-27 2018-09-07 复旦大学附属华山医院 一种建立胃癌的风险预测模型的方法
KR101940657B1 (ko) * 2017-04-24 2019-01-21 (주) 노보믹스 위암의 생물학적 특성에 기반한 군 구분 및 예후 예측 시스템
CN107090503B (zh) * 2017-04-27 2020-06-19 元码基因科技(北京)股份有限公司 探针组合物、基因捕获芯片、试剂盒及其应用
CN107641653B (zh) * 2017-10-20 2021-02-19 南方医科大学南方医院 Macc1-as1探针在制备用于预测胃癌临床预后的诊断试剂中的应用
CN113851185B (zh) * 2021-11-29 2022-04-19 求臻医学科技(北京)有限公司 一种用于非小细胞肺癌患者免疫治疗的预后评估方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2537633T3 (es) * 2004-03-02 2015-06-10 The Johns Hopkins University Mutaciones del gen de PIK3CA en cánceres humanos
WO2007081720A2 (en) * 2006-01-05 2007-07-19 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
CA2648021A1 (en) * 2006-03-31 2007-10-11 Ordway Research Institute, Inc. Prognostic and diagnostic method for cancer therapy
NZ576852A (en) * 2006-10-26 2012-02-24 Genentech Inc Genetic variations (in the phosphatidylinositol 3-kinase regulatory subunit 1 pik3r1 protein) associated with tumors and method of testing for
CA2724348A1 (en) * 2008-05-15 2009-11-19 University Of Southern California Genotype and expression analysis for use in predicting outcome and therapy selection
KR20120061010A (ko) * 2010-11-02 2012-06-12 서울대학교산학협력단 위암 진단 방법
CN103459597B (zh) * 2010-12-13 2016-03-30 社会福祉法人三星生命公益财团 用于预测胃癌预后的标记和使用该标记预测胃癌预后的方法
SG2014010276A (en) * 2011-08-18 2014-03-28 Nestec Sa Compositions and methods for detecting allelic variants

Similar Documents

Publication Publication Date Title
JP2016515390A5 (enExample)
US20200254443A1 (en) Crispr effector system based diagnostics
EP3679130A1 (en) Multi-effector crispr based diagnostic systems
CA3087362A1 (en) Crispr effector system based diagnostics
EP4556576A2 (en) Methods to diagnose and treat acute respiratory infections
KR20190140918A (ko) 바이러스 검출을 위한 crispr 이펙터 시스템 기반 진단
WO2018107129A1 (en) Crispr effector system based diagnostics
JP2014532428A5 (enExample)
EP3029155A3 (en) Method to use gene expression to determine likelihood of clinical outcome of renal cancer
JP2016536991A5 (enExample)
CN113462781A (zh) 使用血浆dna的尺寸和数目畸变检测癌症
JP2017502686A5 (enExample)
CA2829503A1 (en) Method for identifying a subset of polynucleotides from an initial set of polynucleotides corresponding to the human genome for the in vitro determination of the severity of the host response of a patient
Ding et al. Heterosis in early maize ear inflorescence development: a genome-wide transcription analysis for two maize inbred lines and their hybrid
WO2015153732A3 (en) Use of double-stranded dna in exosomes: a novel biomarker in cancer detection
Brockley et al. Sequence-based platforms for discovering biomarkers in liquid biopsy of non-small-cell lung cancer
JP2024512372A (ja) オフターゲットポリヌクレオチド配列決定データに基づく腫瘍の存在の検出
Lie et al. Immunological molecular responses of human retinal pigment epithelial cells to infection with Toxoplasma gondii
Zhang et al. Rare variants of ATG5 are likely to be associated with Chinese patients with systemic lupus erythematosus
CN106399553B (zh) 一种基于多重pcr的人线粒体全基因组高通量测序方法
Haniffa et al. Morphometric, meristic and ISSR marker systems for species identification and evolutionary analysis in five Indian Channids
JP2012527245A5 (enExample)
Fregel et al. Mitochondrial DNA haplogroup phylogeny of the dog: Proposal for a cladistic nomenclature
WO2013163134A2 (en) Biomolecular events in cancer revealed by attractor metagenes
Wąsowska et al. Polygenic risk score and rare variant burden identified by targeted sequencing in a group of patients with pigment epithelial detachment in age-related macular degeneration